Australia markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.8200-0.0500 (-2.67%)
As of 11:46AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8886
Avg. Estimate0.05-0.21-0.40.05
Low estimate-0.31-0.25-1-0.67
High estimate0.46-0.140.091.49
Year ago EPS-0.79-0.46-2.03-0.4
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8886
Avg. Estimate84.51M42.53M265.13M391.03M
Low estimate28.9M38M174M266.1M
High estimate144.57M50.66M328.2M710.2M
Year ago sales24.33M25.79M116.33M265.13M
Sales growth (year/est)247.40%64.90%127.90%47.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.65-0.61-0.43-0.48
Actual EPS-0.79-0.46-0.37-0.5
Difference-0.140.150.06-0.02
Surprise %-21.50%24.60%14.00%-4.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.05-0.21-0.40.05
7 days ago0.05-0.21-0.40.05
30 days ago0.01-0.21-0.440.2
60 days ago-0.040.1-0.280.51
90 days ago-0.070.06-0.340.33
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.106.30%N/AN/AN/A
Next qtr.54.30%N/AN/AN/A
Current year80.30%N/AN/AN/A
Next year112.50%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A